Adrenalin Epinephrine Injection Recalled Due to Incorrect Expiration Date Label
Henry Schein Inc. and Glove Club HSI Gloves Inc. are recalling 1,099 vials of Adrenalin (Epinephrine) Injection because the expiration date on the repack pouch label is incorrect. The product was distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Incorrect expiration date on a risk-of-harm product (epinephrine is essential for anaphylaxis treatment). No injuries have been reported, but expired epinephrine could be ineffective in emergencies, creating significant patient risk.
Plain-English summary
Adrenalin (Epinephrine) Injection 1mg/mL in 1mL single-dose vials is being recalled by Henry Schein Inc. and Glove Club HSI Gloves Inc. due to an incorrect expiration date on the repack pouch label.
The affected repackaged lot (Lot # 39747, with expiration date 01/26) contains incorrect expiration date information on its pouch label. The recall involves 1,099 single-dose vials that were distributed nationwide.
Consumers and healthcare providers should not use this product. Contact your supplier or pharmacist for instructions on returning the affected vials. Healthcare providers should verify the actual expiration date with the manufacturer before administering any of this medication.
The recalled product
- Product
- ADRENALIN (EPINEPHRINE)
- Brand
- ADRENALIN
- Manufacturer
- Henry Schein Inc. and Glove Club HSI Gloves Inc.
- Category
- Drug
- Hazard
- mis-labeling
- incorrect-expiration-date
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Original Lot # 64103
- exp. date 11/24 Repackaged Lot # 39747
- exp. date 01/26
UPCs (1)
- 0342023168016
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ADRENALIN
- HighAdrenalin epinephrine vials recalled nationwide due to temperature-abuse deviations
FDA (Drugs) · 2022-06-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27